Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Nov 2, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

FDA Updates Foreign Operations

Oct 4, 2013

Budget issues and changing global markets are prompting FDA to revise its growing network of overseas offices.

FDA Seeks Metrics to Define Drug Quality

Manufacturing standards are considered key to preventing drug recalls and shortages.
Oct 2, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

FDA Works to Secure Drug Supply Chain

New policies aim to strengthen inspection and oversight processes.
Sep 2, 2013

New FDA supply chain policies aim to strengthen inspection and oversight processes.

Regulatory Roundup

Aug 2, 2013

Appropriate use of medications promises to improve patient care and curb spending, prompting pharmacists, public health authorities, and manufacturers to promote multiple adherence strategies.

Generic Drugs Face Regulatory and Scientific Challenges

FDA funds research to further development of innovative generics.
Aug 2, 2013

FDA funds research to further development of innovative generics, while working to address review and approval issues.

Regulatory Roundup

Compounding, tracking legislation moves forward
Jul 2, 2013

Compounding, tracking legislation moves forward

FDA Urges Greater Focus on Contractor Quality

Outsourcing requires clear policies and written agreements with CMOs.
Jul 2, 2013

Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.

Regulatory Roundup

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.
Jun 2, 2013

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
38%
Breakthrough designations
13%
Protecting the supply chain
38%
Expedited reviews of drug submissions
13%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here